Emerging Technology Partners LLC

Emerging Technology Partners LLC

Emerging Technology Partners LLC

Overview
Date Founded

1900

Headquarters

6 Taft Court,Suite 388,Rockville, MD 20850-5331

Type of Company

Private

Industries

Private Equity & Venture Capital
Investment Services & Portfolio Management

Company Description

Emerging Technology Partners (ETP) invests in companies that develop drugs to address large unmet clinical needs, develop proprietary technology platforms that address rapidly growing markets, recruit experienced management teams with proven industry expertise and provide substantial returns on invested capital. The firm may invest as early as the seed stage and as late as pre-IPO rounds. ETP typically invests between $500,000 and $3 million in a single round, committing as much as $5 million to a company over a series of financings

Executives & Employees

Founder

Managing Member

Vice President

Outside Advisor

Outside Advisor

Outside Advisor

Paths to Emerging Technology Partners LLC
Potential Connections via
Relationship Science
You
Emerging Technology Partners LLC
Recent Transactions
Details Hidden

PharmAthene, Inc. purchases Altimmune, Inc. (Inactive) from HealthCap AB, Greer Capital Advisors LLC, Redmont Venture Partners, Inc., Bonaventure Capital LLC, Emerging Technology Partners LLC, Novartis Venture Fund, Truffle Capital, Esperante BV resulting in a new company Altimmune, Inc.

Details Hidden

Greer Capital Advisors LLC, Redmont Venture Partners, Inc., Bonaventure Capital LLC, Emerging Technology Partners LLC, Altimmune, Inc. (Inactive) purchase Altimmune UK Ltd. from HealthCap AB, Novartis Venture Fund, Truffle Capital, Esperante BV

Transaction Advisors
Escrow Agent

Advised onPharmAthene, Inc. purchases Altimmune, Inc. (Inactive) from HealthCap AB, Greer Capital Advisors LLC, Redmont Venture Partners, Inc., Bonaventure Capital LLC, Emerging Technology Partners LLC, Novartis Venture Fund, Truffle Capital, Esperante BV resulting in a new company Altimmune, Inc.

Advisors & Consultants
Advisor

Co-Founder at Alexandria Real Estate Equities, Inc.

Investments
Details Hidden

Altimmune, Inc. develops vaccines and other biological products. The firm offers products for use in companion and commercial livestock, including cats, dogs, horses, swine, poultry and aquaculture. The company was founded by G. Michael Alder and De-chu Tang in 1997 and is headquartered in Gaithersburg, MD.

Details Hidden

Cellestia Biotech AG manufactures anti-cancer drugs. Its pipeline product includes CB-103, a novel oral pan-NOTCH inhibitor for the treatment of NOTCH dependent leukemia, lymphoma, and solid tumors. The firm holds a worldwide exclusive license on the intellectual property rights for the development and commercialization of CB-103 and related series of close analogues. The company was founded by Freddy Radtke, Michael Bauer, Richard Peck, Dirk Weber and Rajwinder Lehal in 2014 and is headquartered in Basel, Switzerland.

Details Hidden

Applied Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The company was founded by Shoshana Shendelman on January 20, 2016 and is headquartered in New York, NY.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Emerging Technology Partners LLC. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Emerging Technology Partners LLC's profile does not indicate a business or promotional relationship of any kind between RelSci and Emerging Technology Partners LLC.